New aldose reductase inhibitors N99-596 A and B from Streptomyces

Journal of Antibiotics

Volumn 58, Issue 11, 2005, Pages 737-739

  Dong, Yuesheng ^a,b   Yang, Junshan ^a   Ren, Xiao ^b   Zhang, Hua ^b   He, Jiangong ^b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b North China Pharmaceutical Corporation   (China)

Author keywords

Aldose reductase; Inhibitor; Isoflavone rhamnopyranosides

Indexed keywords

5,7,4' TRIHYDROXYISOFLAVONE 3' O ALPHA LEVO RHAMNOPYRANOSIDE; 7,4' DIHYDROXYISOFLAVONE 3' O ALPHA LEVO RHAMNOPYRANOSIDE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ISOFLAVONE DERIVATIVE; N99 596 A; N99 596 B; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; FERMENTATION; IN VITRO STUDY; LENS; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STREPTOMYCES; STREPTOMYCES DIANNANENSIS; SWINE;

ALDEHYDE REDUCTASE; ANIMALS; ENZYME INHIBITORS; ISOFLAVONES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; RHAMNOSE; STREPTOMYCES; SWINE;

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOMYCES; SUS SCROFA;

EID: 29344451624     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2005.100     Document Type: Article

References (9)

1. Nishikawa M, Tsurumi Y, Namiki T, Yoshida K, Okuhara M. Studies on WF-3681, a novel aldose reductase inhibitor I. Taxonomy, fermentation, isolation and characterization. J Antibiot 40: 1394-1399 (1987)
2. Rao KCS, Divakar S, Srinivas M, Babu KN, Karanth NG, Sattur AP. Asperaldin, a new aldose reductase inhibitor from Aspergillus niger CFR-1046. I. Fermentation, isolation and characterization. J Antibiot 56: 173-176 (2003)
3. Rao KCS, Divakar S, Babu KN, Rao AGA, Karanth NG, Sattur AP. Nigerloxin, a novel inhibitor of aldose reductase and lipoxygenase with free radical scavenging activity from Aspergillus niger CFR-W-105. J Antibiot 55: 789-793 (2002)
4. Dvornik E, Simard-Duquesne N, Krami M, Sestanj K, Gabbay KH, Kinoshita JH, Varma SD, Merola LO. Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science 182: 1146-1148 (1973)
5. Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K. Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes. In Vivo 17: 177-180 (2003)
6. Hu JF, Wunderlich D, Sattler I, Thiericke R, Grabley S, Feng XZ. New 2-O-methylrhamno-isoflavones from Streptomyces sp. Nat Prod Res 17: 451-458 (2003)
7. Hazato T, Naganawa H, Kumagai M, Aoyagi T, Umezawa H. β-Galactosidase-inhibiting new isoflavonoids produced by actinomycetes. J Antibiot 32: 217-222 (1979)
8. Umezawa H, Tobe H, Shibamoto N, Nakamura F, Nakamura K, Matsuzaki M, Takeuchi T. Isolation of isoflavones inhibiting DOPA decarboxylase from fungi, and Streptomyces. J Antibiot 28: 947-952 (1975)
9. Komiyama K, Funayama S, Anraku Y, Mita A, Takahashi Y, Omura S, Shimasaki H. Isolation of isoflavonoids possessing antioxidant activity from the fermentation broth of Streptomyces sp. J Antibiot 42: 1344-1349 (1989)